|Last Price$60.13||Day Change (%)-1.65%|
|Open Price$61.36||Day Change ($)-1.01|
|Day Range60.07–61.46||52-Week Range51.79–71.90|
As of Tue 09/30/2014 04:25 PM EST | USD
Twelve-Month Data from St . Jude Medical EnligHTN Renal Denervation System Show Continued Safety and Efficacy for Patients
New Clinical Trial Results Demonstrate Importance of St . Jude Medical Fractional Flow Reserve in Guiding Treatment of NSTEMI Patients
Research and Markets: New Medical Device Regulation & IVD Regulation Conference: London, UK - 09-10 Oct 2014
Research and Markets: Cardiac Pacemaker Market in India 2014
The firm is on track to meet our full-year estimates, and our $60 per share fair value estimate and wide moat rating are intact.
Widening investment-grade credit spreads and rising interest rates lead to losses.
Each succeeding bailout entangles the global financial system even further.
There's steep price for no growth in these portfolios.
Week ending August 4
Industry dynamics are shifting in the wake of Zimmer's Biomet acquisition.